CELIA LEVESQUE: Open Payments
NPI 1316120363 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 6 payments from 4 companies in 2025. Trend: 2023 $341 · 2024 $116 · 2025 $3,230
Consulting: $2,703Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $2,712 |
| Tandem Diabetes Care, Inc. | 1 | $232 |
| Insulet Corporation | 1 | $175 |
| KYOWA KIRIN, INC. | 1 | $110 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, OMNIPOD.
Industry payments across TX — which companies pay providers there.
